Bionano Genomics announced the launch of multiple new products and advancements for its optical genome mapping, OGM, workflow that offer enhanced robustness in sample preparation, decreased turnaround time for DNA labeling and imaging, and improvements in throughput and quality metrics. The new versions of Bionano’s sample prep kits, chips and instrument software address customer feedback and can improve the performance in routine higher volume genome analysis applications. Erik Holmlin, PhD, president and chief executive officer of Bionano, commented, "With these product launches we are significantly expanding the genome analysis capabilities available to the clinical and translational research communities. We look forward to seeing customers benefit from these solutions in the coming months, which we believe can reduce time-to-results and make OGM performance even better. We believe these improvements can enable greater detection of structural variants of all types associated with genetic diseases and complex disorders like cancer."
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on BNGO:
- Bionano Announces Launch of Next-Generation Versions of its Reagent Kits and Chip Consumable, Along with Updates to its Instrument Control and Bionano Access Software for the Optical Genome Mapping Workflow
- Bionano Genomics Announces the Final Speaker Lineup for Symposium 2023 with 30 OGM Presentations and Live Panel Discussions Across a Wide Range of Genetic Disease and Cancer Research Applications
- Bionano Genomics announces speaker lineup for Symposium 2023
- Bionano Genomics announces publication of interim readout from OGM trial
- Bionano teams with Nvidia to develop acceleration platform